894 filings
ARS
2024 FY
LCTX
Lineage Cell Therapeutics Inc
29 Apr 24
Annual report to shareholders
4:50pm
DEFA14A
LCTX
Lineage Cell Therapeutics Inc
29 Apr 24
Additional proxy soliciting materials
4:40pm
DEF 14A
LCTX
Lineage Cell Therapeutics Inc
Definitive proxy
29 Apr 24
4:30pm
424B5
LCTX
Lineage Cell Therapeutics Inc
22 Mar 24
Prospectus supplement for primary offering
4:32pm
8-K
LCTX
Lineage Cell Therapeutics Inc
22 Mar 24
Entry into a Material Definitive Agreement
4:15pm
8-K
4lt9e1 dtdrvb
7 Mar 24
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4:10pm
8-K
j2u0mwx bbbpb
15 Feb 24
Other Events
5:27pm
424B5
qp5g4ycly k47w0oro
6 Feb 24
Prospectus supplement for primary offering
9:25am
8-K
estqxjrm7
6 Feb 24
Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering
9:20am
424B5
p9wmtq
6 Feb 24
Prospectus supplement for primary offering
9:00am
S-8
6o2qm9ridxtq7aen7wkm
13 Nov 23
Registration of securities for employees
4:19pm
8-K
lkcio
9 Nov 23
Lineage Cell Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
4:10pm
8-K
eecomv
7 Sep 23
Departure of Directors or Certain Officers
5:01pm
8-K
uobjx3lnxmrqvzb 5gh3
10 Aug 23
LINEAGE CELL THERAPEUTICS REPORTs SECOND QUARTER 2023 FINANCIAL
4:10pm
ARS
weozrntnqv5x58q1vjva
27 Jul 23
Annual report to shareholders
4:15pm
DEFA14A
7blvmkxn6 km5
27 Jul 23
Additional proxy soliciting materials
4:10pm